274 related articles for article (PubMed ID: 27390851)
1. Important Role of FTO in the Survival of Rare Panresistant Triple-Negative Inflammatory Breast Cancer Cells Facing a Severe Metabolic Challenge.
Singh B; Kinne HE; Milligan RD; Washburn LJ; Olsen M; Lucci A
PLoS One; 2016; 11(7):e0159072. PubMed ID: 27390851
[TBL] [Abstract][Full Text] [Related]
2. Demethylase FTO inhibits the occurrence and development of triple-negative breast cancer by blocking m
Ni J; Lu X; Gao X; Jin C; Mao J
Acta Biochim Biophys Sin (Shanghai); 2024 Jan; 56(1):114-128. PubMed ID: 38151999
[TBL] [Abstract][Full Text] [Related]
3. Cut-like homeobox 1 (CUX1) regulates expression of the fat mass and obesity-associated and retinitis pigmentosa GTPase regulator-interacting protein-1-like (RPGRIP1L) genes and coordinates leptin receptor signaling.
Stratigopoulos G; LeDuc CA; Cremona ML; Chung WK; Leibel RL
J Biol Chem; 2011 Jan; 286(3):2155-70. PubMed ID: 21037323
[TBL] [Abstract][Full Text] [Related]
4. A usable model of "decathlon winner" cancer cells in triple-negative breast cancer: survival of resistant cancer cells in quiescence.
Singh B; Sarli VN; Washburn LJ; Raythatha MR; Lucci A
Oncotarget; 2018 Feb; 9(13):11071-11082. PubMed ID: 29541397
[TBL] [Abstract][Full Text] [Related]
5. FTO Obesity Risk Variants Are Linked to Adipocyte IRX3 Expression and BMI of Children - Relevance of FTO Variants to Defend Body Weight in Lean Children?
Landgraf K; Scholz M; Kovacs P; Kiess W; Körner A
PLoS One; 2016; 11(8):e0161739. PubMed ID: 27560134
[TBL] [Abstract][Full Text] [Related]
6. Interferon-induced transmembrane protein 1 (IFITM1) overexpression enhances the aggressive phenotype of SUM149 inflammatory breast cancer cells in a signal transducer and activator of transcription 2 (STAT2)-dependent manner.
Ogony J; Choi HJ; Lui A; Cristofanilli M; Lewis-Wambi J
Breast Cancer Res; 2016 Feb; 18(1):25. PubMed ID: 26897526
[TBL] [Abstract][Full Text] [Related]
7. Hypomorphism of Fto and Rpgrip1l causes obesity in mice.
Stratigopoulos G; Burnett LC; Rausch R; Gill R; Penn DB; Skowronski AA; LeDuc CA; Lanzano AJ; Zhang P; Storm DR; Egli D; Leibel RL
J Clin Invest; 2016 May; 126(5):1897-910. PubMed ID: 27064284
[TBL] [Abstract][Full Text] [Related]
8. Nutrition modulates Fto and Irx3 gene transcript levels, but does not alter their DNA methylation profiles in rat white adipose tissues.
Nowacka-Woszuk J; Pruszynska-Oszmalek E; Szydlowski M; Szczerbal I
Gene; 2017 Apr; 610():44-48. PubMed ID: 28179100
[TBL] [Abstract][Full Text] [Related]
9. Obesity-associated variants within FTO form long-range functional connections with IRX3.
Smemo S; Tena JJ; Kim KH; Gamazon ER; Sakabe NJ; Gómez-Marín C; Aneas I; Credidio FL; Sobreira DR; Wasserman NF; Lee JH; Puviindran V; Tam D; Shen M; Son JE; Vakili NA; Sung HK; Naranjo S; Acemel RD; Manzanares M; Nagy A; Cox NJ; Hui CC; Gomez-Skarmeta JL; Nóbrega MA
Nature; 2014 Mar; 507(7492):371-5. PubMed ID: 24646999
[TBL] [Abstract][Full Text] [Related]
10. Selection of metastatic breast cancer cells based on adaptability of their metabolic state.
Singh B; Tai K; Madan S; Raythatha MR; Cady AM; Braunlin M; Irving LR; Bajaj A; Lucci A
PLoS One; 2012; 7(5):e36510. PubMed ID: 22570721
[TBL] [Abstract][Full Text] [Related]
11. Highly adaptable triple-negative breast cancer cells as a functional model for testing anticancer agents.
Singh B; Shamsnia A; Raythatha MR; Milligan RD; Cady AM; Madan S; Lucci A
PLoS One; 2014; 9(10):e109487. PubMed ID: 25279830
[TBL] [Abstract][Full Text] [Related]
12. Hypothalamic IRX3: A New Player in the Development of Obesity.
de Araújo TM; Velloso LA
Trends Endocrinol Metab; 2020 May; 31(5):368-377. PubMed ID: 32035736
[TBL] [Abstract][Full Text] [Related]
13. Fat mass and obesity-associated protein (FTO) mediates signal transducer and activator of transcription 3 (STAT3)-drived resistance of breast cancer to doxorubicin.
Wang Y; Cheng Z; Xu J; Lai M; Liu L; Zuo M; Dang L
Bioengineered; 2021 Dec; 12(1):1874-1889. PubMed ID: 34076564
[TBL] [Abstract][Full Text] [Related]
14. Deficiency of Irx5 protects mice from obesity and associated metabolic abnormalities.
Son JE; Dou Z; Kim KH; Hui CC
Int J Obes (Lond); 2022 Nov; 46(11):2029-2039. PubMed ID: 36115924
[TBL] [Abstract][Full Text] [Related]
15. Histone Deacetylase Inhibitor Enhances the Efficacy of MEK Inhibitor through NOXA-Mediated MCL1 Degradation in Triple-Negative and Inflammatory Breast Cancer.
Torres-Adorno AM; Lee J; Kogawa T; Ordentlich P; Tripathy D; Lim B; Ueno NT
Clin Cancer Res; 2017 Aug; 23(16):4780-4792. PubMed ID: 28465444
[No Abstract] [Full Text] [Related]
16. Efficacy of Carboplatin Alone and in Combination with ABT888 in Intracranial Murine Models of BRCA-Mutated and BRCA-Wild-Type Triple-Negative Breast Cancer.
Karginova O; Siegel MB; Van Swearingen AE; Deal AM; Adamo B; Sambade MJ; Bazyar S; Nikolaishvili-Feinberg N; Bash R; O'Neal S; Sandison K; Parker JS; Santos C; Darr D; Zamboni W; Lee YZ; Miller CR; Anders CK
Mol Cancer Ther; 2015 Apr; 14(4):920-30. PubMed ID: 25824335
[TBL] [Abstract][Full Text] [Related]
17. Association of FTO and IRX3 genetic variants to obesity risk in north India.
Srivastava A; Mittal B; Prakash J; Srivastava P; Srivastava N; Srivastava N
Ann Hum Biol; 2016 Sep; 43(5):451-6. PubMed ID: 26440677
[TBL] [Abstract][Full Text] [Related]
18. The effects of CEP-37440, an inhibitor of focal adhesion kinase, in vitro and in vivo on inflammatory breast cancer cells.
Salem I; Alsalahi M; Chervoneva I; Aburto LD; Addya S; Ott GR; Ruggeri BA; Cristofanilli M; Fernandez SV
Breast Cancer Res; 2016 Mar; 18(1):37. PubMed ID: 27009091
[TBL] [Abstract][Full Text] [Related]
19. Changes in FTO and IRX3 gene expression in obese and overweight male adolescents undergoing an intensive lifestyle intervention and the role of FTO genotype in this interaction.
Doaei S; Kalantari N; Izadi P; Salonurmi T; Mosavi Jarrahi A; Rafieifar S; Azizi Tabesh G; Rahimzadeh G; Gholamalizadeh M; Goodarzi MO
J Transl Med; 2019 May; 17(1):176. PubMed ID: 31126299
[TBL] [Abstract][Full Text] [Related]
20. Extensive pleiotropism and allelic heterogeneity mediate metabolic effects of
Sobreira DR; Joslin AC; Zhang Q; Williamson I; Hansen GT; Farris KM; Sakabe NJ; Sinnott-Armstrong N; Bozek G; Jensen-Cody SO; Flippo KH; Ober C; Bickmore WA; Potthoff M; Chen M; Claussnitzer M; Aneas I; Nóbrega MA
Science; 2021 Jun; 372(6546):1085-1091. PubMed ID: 34083488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
